Global AAV Gene Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 91

Published Date: 22 Nov 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global AAV Gene Therapy Drugs market size was valued at US$ 1564 million in 2023 and is forecast to a readjusted size of USD 8306 million by 2030 with a CAGR of 25.7% during review period.

AAV gene therapy drugs are a type of biological therapeutic that utilizes adeno - associated virus (AAV) as a vector to deliver therapeutic genes into a patient's cells for the purpose of treating diseases. AAV is a small, non - enveloped, single - stranded DNA virus. It has several characteristics that make it an attractive vector for gene therapy. The virus has a relatively simple structure consisting of a protein capsid that encloses its genetic material.

This report is a detailed and comprehensive analysis for global AAV Gene Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global AAV Gene Therapy Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global AAV Gene Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global AAV Gene Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global AAV Gene Therapy Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AAV Gene Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AAV Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Avexis/Novartis (Zolgensma), Sarepta Therapeutics (Elevidys), Spark/Roche (Luxturna), PTC Therapeutics (Upstaza), BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), Pfizer, Beijing Innovikang (Pipeline), Suzhou NoJieBeig (Pipeline), Belief BioMed (Pipeline), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
AAV Gene Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
AAV Gene Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    scAAV9 Vector
    AVV2 Vector
    AVV5 Vector
    AAVrh74 Vector

Market segment by Application
    Spinal Muscular Atrophy (SMA)
    Ophthalmic Diseases
    Hemophilia
    Duchenne Muscular Dystrophy (DMD)
    Others

Market segment by players, this report covers
    Avexis/Novartis (Zolgensma)
    Sarepta Therapeutics (Elevidys)
    Spark/Roche (Luxturna)
    PTC Therapeutics (Upstaza)
    BioMarin (Roctavian)
    CSL/uniQure (Hemgenix&Glybera)
    Pfizer
    Beijing Innovikang (Pipeline)
    Suzhou NoJieBeig (Pipeline)
    Belief BioMed (Pipeline)

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AAV Gene Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AAV Gene Therapy Drugs, with revenue, gross margin, and global market share of AAV Gene Therapy Drugs from 2019 to 2024.
Chapter 3, the AAV Gene Therapy Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and AAV Gene Therapy Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AAV Gene Therapy Drugs.
Chapter 13, to describe AAV Gene Therapy Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of AAV Gene Therapy Drugs by Type
        1.3.1 Overview: Global AAV Gene Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global AAV Gene Therapy Drugs Consumption Value Market Share by Type in 2023
        1.3.3 scAAV9 Vector
        1.3.4 AVV2 Vector
        1.3.5 AVV5 Vector
        1.3.6 AAVrh74 Vector
    1.4 Global AAV Gene Therapy Drugs Market by Application
        1.4.1 Overview: Global AAV Gene Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Spinal Muscular Atrophy (SMA)
        1.4.3 Ophthalmic Diseases
        1.4.4 Hemophilia
        1.4.5 Duchenne Muscular Dystrophy (DMD)
        1.4.6 Others
    1.5 Global AAV Gene Therapy Drugs Market Size & Forecast
    1.6 Global AAV Gene Therapy Drugs Market Size and Forecast by Region
        1.6.1 Global AAV Gene Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global AAV Gene Therapy Drugs Market Size by Region, (2019-2030)
        1.6.3 North America AAV Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.4 Europe AAV Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific AAV Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.6 South America AAV Gene Therapy Drugs Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa AAV Gene Therapy Drugs Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Avexis/Novartis (Zolgensma)
        2.1.1 Avexis/Novartis (Zolgensma) Details
        2.1.2 Avexis/Novartis (Zolgensma) Major Business
        2.1.3 Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Product and Solutions
        2.1.4 Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Avexis/Novartis (Zolgensma) Recent Developments and Future Plans
    2.2 Sarepta Therapeutics (Elevidys)
        2.2.1 Sarepta Therapeutics (Elevidys) Details
        2.2.2 Sarepta Therapeutics (Elevidys) Major Business
        2.2.3 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Product and Solutions
        2.2.4 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sarepta Therapeutics (Elevidys) Recent Developments and Future Plans
    2.3 Spark/Roche (Luxturna)
        2.3.1 Spark/Roche (Luxturna) Details
        2.3.2 Spark/Roche (Luxturna) Major Business
        2.3.3 Spark/Roche (Luxturna) AAV Gene Therapy Drugs Product and Solutions
        2.3.4 Spark/Roche (Luxturna) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Spark/Roche (Luxturna) Recent Developments and Future Plans
    2.4 PTC Therapeutics (Upstaza)
        2.4.1 PTC Therapeutics (Upstaza) Details
        2.4.2 PTC Therapeutics (Upstaza) Major Business
        2.4.3 PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Product and Solutions
        2.4.4 PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 PTC Therapeutics (Upstaza) Recent Developments and Future Plans
    2.5 BioMarin (Roctavian)
        2.5.1 BioMarin (Roctavian) Details
        2.5.2 BioMarin (Roctavian) Major Business
        2.5.3 BioMarin (Roctavian) AAV Gene Therapy Drugs Product and Solutions
        2.5.4 BioMarin (Roctavian) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 BioMarin (Roctavian) Recent Developments and Future Plans
    2.6 CSL/uniQure (Hemgenix&Glybera)
        2.6.1 CSL/uniQure (Hemgenix&Glybera) Details
        2.6.2 CSL/uniQure (Hemgenix&Glybera) Major Business
        2.6.3 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Product and Solutions
        2.6.4 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 CSL/uniQure (Hemgenix&Glybera) Recent Developments and Future Plans
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer AAV Gene Therapy Drugs Product and Solutions
        2.7.4 Pfizer AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Pfizer Recent Developments and Future Plans
    2.8 Beijing Innovikang (Pipeline)
        2.8.1 Beijing Innovikang (Pipeline) Details
        2.8.2 Beijing Innovikang (Pipeline) Major Business
        2.8.3 Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Product and Solutions
        2.8.4 Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Beijing Innovikang (Pipeline) Recent Developments and Future Plans
    2.9 Suzhou NoJieBeig (Pipeline)
        2.9.1 Suzhou NoJieBeig (Pipeline) Details
        2.9.2 Suzhou NoJieBeig (Pipeline) Major Business
        2.9.3 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Product and Solutions
        2.9.4 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Suzhou NoJieBeig (Pipeline) Recent Developments and Future Plans
    2.10 Belief BioMed (Pipeline)
        2.10.1 Belief BioMed (Pipeline) Details
        2.10.2 Belief BioMed (Pipeline) Major Business
        2.10.3 Belief BioMed (Pipeline) AAV Gene Therapy Drugs Product and Solutions
        2.10.4 Belief BioMed (Pipeline) AAV Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Belief BioMed (Pipeline) Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global AAV Gene Therapy Drugs Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of AAV Gene Therapy Drugs by Company Revenue
        3.2.2 Top 3 AAV Gene Therapy Drugs Players Market Share in 2023
        3.2.3 Top 6 AAV Gene Therapy Drugs Players Market Share in 2023
    3.3 AAV Gene Therapy Drugs Market: Overall Company Footprint Analysis
        3.3.1 AAV Gene Therapy Drugs Market: Region Footprint
        3.3.2 AAV Gene Therapy Drugs Market: Company Product Type Footprint
        3.3.3 AAV Gene Therapy Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global AAV Gene Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
    4.2 Global AAV Gene Therapy Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global AAV Gene Therapy Drugs Consumption Value Market Share by Application (2019-2024)
    5.2 Global AAV Gene Therapy Drugs Market Forecast by Application (2025-2030)

6 North America
    6.1 North America AAV Gene Therapy Drugs Consumption Value by Type (2019-2030)
    6.2 North America AAV Gene Therapy Drugs Market Size by Application (2019-2030)
    6.3 North America AAV Gene Therapy Drugs Market Size by Country
        6.3.1 North America AAV Gene Therapy Drugs Consumption Value by Country (2019-2030)
        6.3.2 United States AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        6.3.3 Canada AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        6.3.4 Mexico AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe AAV Gene Therapy Drugs Consumption Value by Type (2019-2030)
    7.2 Europe AAV Gene Therapy Drugs Consumption Value by Application (2019-2030)
    7.3 Europe AAV Gene Therapy Drugs Market Size by Country
        7.3.1 Europe AAV Gene Therapy Drugs Consumption Value by Country (2019-2030)
        7.3.2 Germany AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.3 France AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.5 Russia AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        7.3.6 Italy AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific AAV Gene Therapy Drugs Market Size by Region
        8.3.1 Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Region (2019-2030)
        8.3.2 China AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.3 Japan AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.4 South Korea AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.5 India AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        8.3.7 Australia AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)

9 South America
    9.1 South America AAV Gene Therapy Drugs Consumption Value by Type (2019-2030)
    9.2 South America AAV Gene Therapy Drugs Consumption Value by Application (2019-2030)
    9.3 South America AAV Gene Therapy Drugs Market Size by Country
        9.3.1 South America AAV Gene Therapy Drugs Consumption Value by Country (2019-2030)
        9.3.2 Brazil AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        9.3.3 Argentina AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa AAV Gene Therapy Drugs Market Size by Country
        10.3.1 Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Country (2019-2030)
        10.3.2 Turkey AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)
        10.3.4 UAE AAV Gene Therapy Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 AAV Gene Therapy Drugs Market Drivers
    11.2 AAV Gene Therapy Drugs Market Restraints
    11.3 AAV Gene Therapy Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 AAV Gene Therapy Drugs Industry Chain
    12.2 AAV Gene Therapy Drugs Upstream Analysis
    12.3 AAV Gene Therapy Drugs Midstream Analysis
    12.4 AAV Gene Therapy Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global AAV Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global AAV Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global AAV Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global AAV Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Avexis/Novartis (Zolgensma) Company Information, Head Office, and Major Competitors
 Table 6. Avexis/Novartis (Zolgensma) Major Business
 Table 7. Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Product and Solutions
 Table 8. Avexis/Novartis (Zolgensma) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Avexis/Novartis (Zolgensma) Recent Developments and Future Plans
 Table 10. Sarepta Therapeutics (Elevidys) Company Information, Head Office, and Major Competitors
 Table 11. Sarepta Therapeutics (Elevidys) Major Business
 Table 12. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Product and Solutions
 Table 13. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Sarepta Therapeutics (Elevidys) Recent Developments and Future Plans
 Table 15. Spark/Roche (Luxturna) Company Information, Head Office, and Major Competitors
 Table 16. Spark/Roche (Luxturna) Major Business
 Table 17. Spark/Roche (Luxturna) AAV Gene Therapy Drugs Product and Solutions
 Table 18. Spark/Roche (Luxturna) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. PTC Therapeutics (Upstaza) Company Information, Head Office, and Major Competitors
 Table 20. PTC Therapeutics (Upstaza) Major Business
 Table 21. PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Product and Solutions
 Table 22. PTC Therapeutics (Upstaza) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. PTC Therapeutics (Upstaza) Recent Developments and Future Plans
 Table 24. BioMarin (Roctavian) Company Information, Head Office, and Major Competitors
 Table 25. BioMarin (Roctavian) Major Business
 Table 26. BioMarin (Roctavian) AAV Gene Therapy Drugs Product and Solutions
 Table 27. BioMarin (Roctavian) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. BioMarin (Roctavian) Recent Developments and Future Plans
 Table 29. CSL/uniQure (Hemgenix&Glybera) Company Information, Head Office, and Major Competitors
 Table 30. CSL/uniQure (Hemgenix&Glybera) Major Business
 Table 31. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Product and Solutions
 Table 32. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. CSL/uniQure (Hemgenix&Glybera) Recent Developments and Future Plans
 Table 34. Pfizer Company Information, Head Office, and Major Competitors
 Table 35. Pfizer Major Business
 Table 36. Pfizer AAV Gene Therapy Drugs Product and Solutions
 Table 37. Pfizer AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Pfizer Recent Developments and Future Plans
 Table 39. Beijing Innovikang (Pipeline) Company Information, Head Office, and Major Competitors
 Table 40. Beijing Innovikang (Pipeline) Major Business
 Table 41. Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Product and Solutions
 Table 42. Beijing Innovikang (Pipeline) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Beijing Innovikang (Pipeline) Recent Developments and Future Plans
 Table 44. Suzhou NoJieBeig (Pipeline) Company Information, Head Office, and Major Competitors
 Table 45. Suzhou NoJieBeig (Pipeline) Major Business
 Table 46. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Product and Solutions
 Table 47. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Suzhou NoJieBeig (Pipeline) Recent Developments and Future Plans
 Table 49. Belief BioMed (Pipeline) Company Information, Head Office, and Major Competitors
 Table 50. Belief BioMed (Pipeline) Major Business
 Table 51. Belief BioMed (Pipeline) AAV Gene Therapy Drugs Product and Solutions
 Table 52. Belief BioMed (Pipeline) AAV Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. Belief BioMed (Pipeline) Recent Developments and Future Plans
 Table 54. Global AAV Gene Therapy Drugs Revenue (USD Million) by Players (2019-2024)
 Table 55. Global AAV Gene Therapy Drugs Revenue Share by Players (2019-2024)
 Table 56. Breakdown of AAV Gene Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 57. Market Position of Players in AAV Gene Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 58. Head Office of Key AAV Gene Therapy Drugs Players
 Table 59. AAV Gene Therapy Drugs Market: Company Product Type Footprint
 Table 60. AAV Gene Therapy Drugs Market: Company Product Application Footprint
 Table 61. AAV Gene Therapy Drugs New Market Entrants and Barriers to Market Entry
 Table 62. AAV Gene Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
 Table 63. Global AAV Gene Therapy Drugs Consumption Value (USD Million) by Type (2019-2024)
 Table 64. Global AAV Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
 Table 65. Global AAV Gene Therapy Drugs Consumption Value Forecast by Type (2025-2030)
 Table 66. Global AAV Gene Therapy Drugs Consumption Value by Application (2019-2024)
 Table 67. Global AAV Gene Therapy Drugs Consumption Value Forecast by Application (2025-2030)
 Table 68. North America AAV Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 69. North America AAV Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 70. North America AAV Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 71. North America AAV Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 72. North America AAV Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 73. North America AAV Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 74. Europe AAV Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 75. Europe AAV Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 76. Europe AAV Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 77. Europe AAV Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 78. Europe AAV Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 79. Europe AAV Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 80. Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 81. Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 82. Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 83. Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 84. Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 85. Asia-Pacific AAV Gene Therapy Drugs Consumption Value by Region (2025-2030) & (USD Million)
 Table 86. South America AAV Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 87. South America AAV Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 88. South America AAV Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 89. South America AAV Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 90. South America AAV Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 91. South America AAV Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 92. Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 93. Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 94. Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 95. Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 96. Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 97. Middle East & Africa AAV Gene Therapy Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 98. Global Key Players of AAV Gene Therapy Drugs Upstream (Raw Materials)
 Table 99. Global AAV Gene Therapy Drugs Typical Customers


List of Figures
 Figure 1. AAV Gene Therapy Drugs Picture
 Figure 2. Global AAV Gene Therapy Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global AAV Gene Therapy Drugs Consumption Value Market Share by Type in 2023
 Figure 4. scAAV9 Vector
 Figure 5. AVV2 Vector
 Figure 6. AVV5 Vector
 Figure 7. AAVrh74 Vector
 Figure 8. Global AAV Gene Therapy Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 9. AAV Gene Therapy Drugs Consumption Value Market Share by Application in 2023
 Figure 10. Spinal Muscular Atrophy (SMA) Picture
 Figure 11. Ophthalmic Diseases Picture
 Figure 12. Hemophilia Picture
 Figure 13. Duchenne Muscular Dystrophy (DMD) Picture
 Figure 14. Others Picture
 Figure 15. Global AAV Gene Therapy Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 16. Global AAV Gene Therapy Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 17. Global Market AAV Gene Therapy Drugs Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 18. Global AAV Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 19. Global AAV Gene Therapy Drugs Consumption Value Market Share by Region in 2023
 Figure 20. North America AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 21. Europe AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 22. Asia-Pacific AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 23. South America AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 24. Middle East & Africa AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 25. Company Three Recent Developments and Future Plans
 Figure 26. Global AAV Gene Therapy Drugs Revenue Share by Players in 2023
 Figure 27. AAV Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 28. Market Share of AAV Gene Therapy Drugs by Player Revenue in 2023
 Figure 29. Top 3 AAV Gene Therapy Drugs Players Market Share in 2023
 Figure 30. Top 6 AAV Gene Therapy Drugs Players Market Share in 2023
 Figure 31. Global AAV Gene Therapy Drugs Consumption Value Share by Type (2019-2024)
 Figure 32. Global AAV Gene Therapy Drugs Market Share Forecast by Type (2025-2030)
 Figure 33. Global AAV Gene Therapy Drugs Consumption Value Share by Application (2019-2024)
 Figure 34. Global AAV Gene Therapy Drugs Market Share Forecast by Application (2025-2030)
 Figure 35. North America AAV Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 36. North America AAV Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
 Figure 37. North America AAV Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 38. United States AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 39. Canada AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 40. Mexico AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 41. Europe AAV Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 42. Europe AAV Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
 Figure 43. Europe AAV Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 45. France AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific AAV Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific AAV Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific AAV Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 52. China AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 53. Japan AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 54. South Korea AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 55. India AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 56. Southeast Asia AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 57. Australia AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 58. South America AAV Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 59. South America AAV Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
 Figure 60. South America AAV Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 61. Brazil AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 62. Argentina AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 63. Middle East & Africa AAV Gene Therapy Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 64. Middle East & Africa AAV Gene Therapy Drugs Consumption Value Market Share by Application (2019-2030)
 Figure 65. Middle East & Africa AAV Gene Therapy Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 66. Turkey AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 67. Saudi Arabia AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 68. UAE AAV Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 69. AAV Gene Therapy Drugs Market Drivers
 Figure 70. AAV Gene Therapy Drugs Market Restraints
 Figure 71. AAV Gene Therapy Drugs Market Trends
 Figure 72. Porters Five Forces Analysis
 Figure 73. AAV Gene Therapy Drugs Industrial Chain
 Figure 74. Methodology
 Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Avexis/Novartis (Zolgensma)
Sarepta Therapeutics (Elevidys)
Spark/Roche (Luxturna)
PTC Therapeutics (Upstaza)
BioMarin (Roctavian)
CSL/uniQure (Hemgenix&Glybera)
Pfizer
Beijing Innovikang (Pipeline)
Suzhou NoJieBeig (Pipeline)
Belief BioMed (Pipeline)

Related Reports

Global AAV Gene Therapy Drugs Supply, Demand and Key Producers, 2024-2030

Global AAV Gene Therapy Drugs Supply, Demand and Key Producers, 2024-2030

date 22 Nov 2024

date Pharma & Healthcare

The global AAV Gene Therapy Drugs market size is expected to reach $ 8306 million by 2030, rising at a market growth of 25.7% CAGR during the forecast period (2024-2030).

Product Tags

AAV Gene Therapy Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>